Csenge Advisory Group’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,478	Closed	-$316K	–	613
2022 Q2	$316K	Sell	1,478 -715	-33%	-$175K	0.03%	437
2022 Q1	$623K	Buy	2,193 +530	+32%	+$163K	0.05%	325
2021 Q4	$620K	Sell	1,663 -49	-3%	-$19K	0.06%	292
2021 Q3	$713K	Buy	1,712 +49	+3%	+$20.4K	0.06%	292
2021 Q2	$620K	Buy	1,663 +310	+23%	+$104K	0.06%	293
2021 Q1	$415K	Sell	1,353 -25	-2%	-$6.95K	0.04%	323
2020 Q4	$344K	Sell	1,378 -196	-12%	-$46.7K	0.04%	294
2020 Q3	$367K	Buy	1,574 +5	+0.3%	+$1.04K	0.05%	261
2020 Q2	$274K	Sell	1,569 -528	-25%	-$84.3K	0.04%	290
2020 Q1	$265K	Buy	2,097 +743	+55%	+$111K	0.07%	234
2019 Q4	$207K	Buy	+1,354	New	+$187K	0.05%	274
2018 Q4	–	Sell	-714	Closed	-$91K	–	461
2018 Q3	$91K	Buy	+714	New	+$88.1K	0.04%	246